Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.

Abstract

Changes in Testing for Human Immunodeficiency Virus, Sexually Transmitted Infections, andHepatitis C Virus in Opioid Treatment Programs Opioid dependence is a risk factor for human immunodeficiency virus (HIV), sexually transmitted infections (STIs), and hepatitis C virus (HCV) infection.1 Opioid treatment programs, which provide treatment to more than 300… (More)
DOI: 10.1001/jama.2013.278456

Topics

2 Figures and Tables

Slides referencing similar topics